Together our in vitro and in vivo data point toward several promoting effects of ST3GAL1 in melanoma progression, and provide strong evidence that silencing of ST3GAL1 inhibits the metastatic process in vivo. This evidence concerns the gene ST3GAL1 and melanoma.